International Journal Of Modern
Pharmaceutical Research

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Science & Pharmacy Professional

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

INTERNATIONAL JOURNAL OF MODERN PHARMACEUTICAL RESEARCH has been indexed and abstracted by various international reputed agencies like : Google Scholar , Index Copernicus , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , Cosmos Impact Factor , Scientific Indexing Services (SIS) , Web of Science Group (Under Process) , IFSIJ Measure of Journal Quality , International Scientific Indexing, UAE (ISI) (Under Process) , IP Indexing (IP Value 2.42) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing (ISI) , Scope Database , ABCD Index , Academia  and many more.
ISSN 2319-5878
IMPACT FACTOR: 6.669

Abstract

POLYCYSTIC OVARY SYNDROME: A COMPLETE REVIEW FOR RISK FACTORS, DISEASE AND DIAGNOSIS MANAGEMENT

C. Mohana*, K. Manasa, S. Pushpa Sree, N. Priyanka and M. Kishore Babu

ABSTRACT

Polycystic ovary syndrome (PCOS) is an endocrine-gynecology disorder affecting many women of childbearing age. Although a part of the involved mechanism in PCOS occurrence is discovered, the exact etiology and pathophysiology are not comprehensively understood yet. Androgen excess (male hormone excess), seen in 60-80% of girls and women with PCOS, is a key problem in the disorder and likely comes from ovaries in most women. The evidence suggests the several different external and internal factors which includes hyperandrogenism, insulin resistance, genetic, epigenetics and environmental factors. PCOS increases the risk of further complications like anxiety, depression, metabolic syndrome, cardiovascular diseases and type 2 diabetes mellitus, cardiovascular diseases. However, the symptoms can be successfully managed with proper medication and lifestyle interventions. In this review article, about PCOD are clearly explored. Physicians suggested to use anti androgen agents, insulin sensitizers, (combined) oral contraceptives, and ovulation inducers. According to United states food and drug administration (USFDA) there is no medication approved particularly for PCOD and all medications mentioned are off label used.

[Full Text Article] [Certificate Download]

Indexing

News

  • Call for Paper

    IJMPR  Invited to submit your valuable manuscripts for Coming Issue.

  • IJMPR: MAY ISSUE PUBLISHED

    MAY 2024 Issue has been successfully launched IJMPR on 1 MAY 2024.

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • IJMPR: New Impact Factor

    IJMPR Impact Factor has been Increased to 6.669 for Year 2024.

  • NEW ISSUE PUBLISHED

    Its Our pleasure to inform you that, IJMPR 1 May 2023 Issue has been Published, Kindly check it on https://ijmpronline.com/current-issues

Best Paper Awards

IJMPR is awarding one article from each issue as "BEST PAPER AWARD", Winner will get a "Certificate of Appreciation" along with cash reward. The best paper of the issue is as follows :

Best Article of current issue

Download Article : Click here

Powered By IJMPR | All Right Reserved

IJMPR